All these data indicate that YAP/TAZ contributes to the invasive behavior of RA synovial fibroblasts and interrupting YAP/TAZ transcriptional activity is a viable strategy to explore as an alternative therapy for RA. The gene discussed is WWTR1; the disease is rheumatoid arthritis.